Compared etifoxine to lorazepam (Ativan®) – for alertness and cognitive functions in elderly patients

Etifoxine impairs neither alertness nor cognitive functions of the elderly: A randomized, double-blind, placebo-controlled crossover study D. Deplanque, F. Machuron, N. Waucquier, E. Jozefowicz, S. Duhem, S. Somers, O. Colin, A. Duhamel, R. Bordet

2019-11-08T19:51:41+00:00Timeline|

Safety Profile of Etifoxine: A French Pharmacovigilance Survey

Adverse drug reactions (ADRs) from over 14 million prescriptions of (Stresam®) etifoxine were reviewed and analyzed by the French National Agency for the Safety of Medicines and Health Products, between 2000 and 2012. The average incidence of ADRs was 0.0021% (21 per million treatments) and no cases of abuse, misuse [...]

2019-11-08T19:51:35+00:00Timeline|

Compared etifoxine to alprazolam (Xanax®) – for safety and efficacy

Etifoxine Versus Alprazolam for the Treatment of Adjustment Disorder with Anxiety: a Randomized Controlled Trial Dan J. Stein

2019-11-08T19:51:22+00:00Timeline|

Compared etifoxine to lorazepam (Ativan®) – established non-inferiority in adjustment disorder with anxiety ADWA

Efficacy of etifoxine compared to lorazepam monotherapy in the treatment of patients with adjustment disorders with anxiety: a double-blind controlled study in general practice N. Nguyen, E. Fakra, V. Pradel, E. Jouve, C. Alquier, M-E. Le Guern, J. Micallef, and O. Blin

2019-11-08T19:51:12+00:00Timeline|

Compared etifoxine with lorazepam (Ativan®) – for sedative and amnesic effects

A double blind parallel group placebo controlled comparison of sedative and amnesic effects of etifoxine and lorazepam in healthy subjects J. Micallef, C. Soubrouillarda, F. Gueta, M. E. Le Guernb, C. Alquierb, B. Bruguerollea, O. Blin

2019-11-08T19:51:00+00:00Timeline|